Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H F Hoff

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Circulation|June 1, 1988
Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patientsH F Hoff, G J Beck, C I Skibinski, et al.
Arteriosclerosis (Dallas, Tex.)|July 1, 1989
Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophagesH F Hoff, J O'Neil, G M Chisolm, et al.
Circulation|August 1, 1992
Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patientsM D Cressman, R J Heyka, E P Paganini, et al.
Comparative Biochemistry and Physiology. B, Comparative Biochemistry|January 1, 1976
Comparative studies on plasma low density lipoproteins from pig and manR L Jackson, O D Taunton, R Segura, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 1, 1978
Correlation of apolipoprotein B retention with the structure of atherosclerotic plaques from human aortasH F Hoff, C L Heideman, J W Gaubatz, et al.
Biochimica Et Biophysica Acta|May 25, 1979
Characterization of low density lipoprotein-like particle in the human aorta from grossly normal and atherosclerotic regionsH F Hoff, W A Bradley, C L Heideman, et al.
Circulation Research|July 1, 1975
Localization patterns of plasma apolipoproteins in human atherosclerotic lesionsH F Hoff, C L Heideman, R L Jackson, et al.
Circulation Research|January 1, 1977
Quantification of apolipoprotein B in grossly normal human aortaH F Hoff, C L Heideman, J W Gaubatz, et al.
The Journal of Biological Chemistry|July 10, 1999
Protein adducts of iso[4]levuglandin E2, a product of the isoprostane pathway, in oxidized low density lipoproteinR G Salomon, W Sha, C Brame, et al.
Chemical Research in Toxicology|May 1, 1997
Levuglandin E2-protein adducts in human plasma and vasculatureR G Salomon, G Subbanagounder, J O'Neil, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Circulation|June 1, 1988
Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patientsH F Hoff, G J Beck, C I Skibinski, et al.
Arteriosclerosis (Dallas, Tex.)|July 1, 1989
Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophagesH F Hoff, J O'Neil, G M Chisolm, et al.
Circulation|August 1, 1992
Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patientsM D Cressman, R J Heyka, E P Paganini, et al.
Comparative Biochemistry and Physiology. B, Comparative Biochemistry|January 1, 1976
Comparative studies on plasma low density lipoproteins from pig and manR L Jackson, O D Taunton, R Segura, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 1, 1978
Correlation of apolipoprotein B retention with the structure of atherosclerotic plaques from human aortasH F Hoff, C L Heideman, J W Gaubatz, et al.
Biochimica Et Biophysica Acta|May 25, 1979
Characterization of low density lipoprotein-like particle in the human aorta from grossly normal and atherosclerotic regionsH F Hoff, W A Bradley, C L Heideman, et al.
Circulation Research|July 1, 1975
Localization patterns of plasma apolipoproteins in human atherosclerotic lesionsH F Hoff, C L Heideman, R L Jackson, et al.
Circulation Research|January 1, 1977
Quantification of apolipoprotein B in grossly normal human aortaH F Hoff, C L Heideman, J W Gaubatz, et al.
The Journal of Biological Chemistry|July 10, 1999
Protein adducts of iso[4]levuglandin E2, a product of the isoprostane pathway, in oxidized low density lipoproteinR G Salomon, W Sha, C Brame, et al.
Chemical Research in Toxicology|May 1, 1997
Levuglandin E2-protein adducts in human plasma and vasculatureR G Salomon, G Subbanagounder, J O'Neil, et al.
Pageof 10